Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Quercetin

"COPD Subjects will be asked to avoid quercetin rich diet for one week and then asked to take one of the following for 1 week~1. Quercetin 500 mg/350 mg of vitamin C and 10 mg niacin~2. Quercetin 1000 mg/350 mg of vitamin C and 10 mg niacin~3. Quercetin 2000 mg/350 mg of vitamin C and 10 mg niacin"

OTHER

Placebo - sugar chew

COPD Subjects will be asked to avoid quercetin rich diet for one week and then asked to take placebo (sugar chew containing 350 mg of vitamin C and 10 mg niacin)

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Quercegen Pharmaceuticals

INDUSTRY

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of Michigan

OTHER

NCT01708278 - Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter